147 related articles for article (PubMed ID: 10704067)
21. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
Chen RH; Kadner A; Mitchell RN; Adams DH
J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
[TBL] [Abstract][Full Text] [Related]
22. Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of alpha-galactosidase-treated porcine cartilage.
Stone KR; Ayala G; Goldstein J; Hurst R; Walgenbach A; Galili U
Transplantation; 1998 Jun; 65(12):1577-83. PubMed ID: 9665073
[TBL] [Abstract][Full Text] [Related]
23. In vivo neutralization of naturally existing antibodies against linear alpha(1,3)-galactosidic carbohydrate epitopes by multivalent antigen presentation: a solution for the first hurdle of pig-to-human xenotransplantation.
Duthaler RO; Ernst B; Fischer R; Katopodis AG; Kinzy W; Marterer W; Oehrlein R; Streiff MB; Thoma G
Chimia (Aarau); 2010; 64(1-2):23-8. PubMed ID: 21137679
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
[TBL] [Abstract][Full Text] [Related]
25. Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.
Baumann BC; Forte P; Hawley RJ; Rieben R; Schneider MK; Seebach JD
J Immunol; 2004 May; 172(10):6460-7. PubMed ID: 15128838
[TBL] [Abstract][Full Text] [Related]
26. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity.
Watier H; Guillaumin JM; Piller F; Lacord M; Thibault G; Lebranchu Y; Monsigny M; Bardos P
Transplantation; 1996 Jul; 62(1):105-13. PubMed ID: 8693523
[TBL] [Abstract][Full Text] [Related]
27. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
[TBL] [Abstract][Full Text] [Related]
28. Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection.
Collins BH; Cotterell AH; McCurry KR; Alvarado CG; Magee JC; Parker W; Platt JL
J Immunol; 1995 May; 154(10):5500-10. PubMed ID: 7537308
[TBL] [Abstract][Full Text] [Related]
29. Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose alpha(1-3)galactose reactive lectin.
Vaughan HA; McKenzie IF; Sandrin MS
Transplantation; 1995 Jan; 59(1):102-9. PubMed ID: 7839409
[TBL] [Abstract][Full Text] [Related]
30. Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A.
Park S; Kim WH; Choi SY; Kim YJ
J Korean Med Sci; 2009 Dec; 24(6):1126-31. PubMed ID: 19949670
[TBL] [Abstract][Full Text] [Related]
31. Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation.
Sandrin MS; Osman N; McKenzie IF
Front Biosci; 1997 Apr; 2():e1-11. PubMed ID: 9159186
[TBL] [Abstract][Full Text] [Related]
32. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation.
Richards AC; Davies HF; McLaughlin ML; Copeman LS; Holmes BJ; Dos Santos Cruz G; Bycroft S; Chavez G; White DJ; Schuurman HJ; Cozzi E
Transplantation; 2002 Mar; 73(6):881-9. PubMed ID: 11923687
[TBL] [Abstract][Full Text] [Related]
33. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and anti-Gal column immunoadsorption.
Zhang JP; Blum MG; Chang AC; Shyr Y; Blair KS; Awwad M; Pierson RN
Xenotransplantation; 1999 Nov; 6(4):249-61. PubMed ID: 10704068
[TBL] [Abstract][Full Text] [Related]
34. Humoral human xenoreactivity against isolated pig pancreatic islets.
Kin T; Nakajima Y; Aomatsu Y; Kanehiro H; Hisanaga M; Ko S; Ohyama T; Nakano H
Surg Today; 2000; 30(9):821-6. PubMed ID: 11039711
[TBL] [Abstract][Full Text] [Related]
35. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.
Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B
Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844
[TBL] [Abstract][Full Text] [Related]
36. Multivalent Galalpha1,3Gal-substitution makes recombinant mucin-immunoglobulins efficient absorbers of anti-pig antibodies.
Liu J; Weintraub A; Holgersson J
Xenotransplantation; 2003 Mar; 10(2):149-63. PubMed ID: 12588648
[TBL] [Abstract][Full Text] [Related]
37. Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination.
Cattan P; Zhang B; Braet F; Atia N; Conti F; Conjeaud H; Weill B; Chereau C; Houssin D; Calmus Y
Transplantation; 1996 Sep; 62(6):803-10. PubMed ID: 8824481
[TBL] [Abstract][Full Text] [Related]
38. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts.
McKenzie IF; Xing PX; Vaughan HA; Prenzoska J; Dabkowski PL; Sandrin MS
Transpl Immunol; 1994 Jun; 2(2):81-6. PubMed ID: 7953322
[TBL] [Abstract][Full Text] [Related]
39. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression.
Omori T; Nishida T; Komoda H; Fumimoto Y; Ito T; Sawa Y; Gao C; Nakatsu S; Shirakura R; Miyagawa S
Xenotransplantation; 2006 Sep; 13(5):455-64. PubMed ID: 16925670
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.
Dalmasso AP; Vercellotti GM; Fischel RJ; Bolman RM; Bach FH; Platt JL
Am J Pathol; 1992 May; 140(5):1157-66. PubMed ID: 1580328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
